- Research works
- 43 ▲ 67% vs 2013–17
- Citations
- 517 12.1 per fractional work
- Top-10% rate
- 4.8% record average 16.5%
- Open access
- 29% world 28%
Not ranked overall: Boundless Bio (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 42.3×. Every wedge is a field page.
Which keywords describe research at Boundless Bio (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cancer Genomics, Mutational Signatures, Clinical Trials, Conflict of Interest, Pharmaceutical Industry, Lithium-ion Batteries and Energy Efficiency.
- Metastatic Breast Cancer
- Adhesive Joints
- Quality of Life
- Energy Efficiency
- Nanoparticles
- Pharmaceutical Industry
- Clinical Trials
- Cancer Genomics
- Targeted Therapy
- Mutational Signatures
- Conflict of Interest
- Climate Change
- Lithium-ion Batteries
- Environmental Impact
- Mechanical Properties
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Targeted Therapy4▲ 48×2 topics
- Cancer Genomics4▲ 155×1 topic
- Mutational Signatures4▲ 155×1 topic
- Clinical Trials3▲ 11×3 topics
- Conflict of Interest2▲ 350×1 topic
- Pharmaceutical Industry2▲ 116×1 topic
- Climate Change2▲ 1.37×6 topics
- Nanoparticles2▲ 2.8×5 topics
- Lithium-ion Batteries2▲ 14×3 topics
- Energy Efficiency1▲ 4.3×4 topics
- Environmental Impact1▲ 2.4×5 topics
- Quality of Life1▲ 2.2×4 topics
- Mechanical Properties1▲ 2.8×4 topics
- Adhesive Joints1▲ 29×2 topics
- Chemotherapy-Induced Peripheral Neuropathy1▲ 47×1 topic
- Metastatic Breast Cancer1▲ 36×2 topics
- Taxanes1▲ 47×1 topic
Which research topics does Boundless Bio (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Pharmaceutical industry and healthcare, CRISPR and Genetic Engineering and RNA modifications and cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 2 works
- 2 Pharmaceutical industry and healthcare Pharmacology 2 works
- 3 CRISPR and Genetic Engineering Molecular Biology 1 works
- 4 RNA modifications and cancer Molecular Biology 1 works
- 5 Colorectal Cancer Treatments and Studies Oncology 0 works
- 6 Neuroblastoma Research and Treatments Neurology 0 works
- 7 Sustainability in Higher Education Education 0 works
- 8 Metal-Catalyzed Oxygenation Mechanisms Inorganic Chemistry 0 works
- 9 Epigenetics and DNA Methylation Molecular Biology 0 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boundless Bio (United States)'s research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.